Researchers at Washington University School of Medicine in St. Louis found the same mutation that makes TB bacteria resist a first-line drug also draws out a potentially weaker immune response in mice.
“As the bacteria become drug-resistant, they change physiologically and trick the immune system to behave differently,” said senior study author Shabaana Khader, PhD. “If we’re going to fight TB bacteria effectively, we’re going to have to understand what the drug-resistant bacteria are doing to the immune system to elicit protection.”
The researchers looked at immune responses in mice infected with Mycobacterium tuberculosis, the bacteria that cause TB. They compared a strain resistant to all first- and many second-line antibiotics with a drug-sensitive TB strain.
The mice’s immune systems fought the sensitive bacteria by releasing a powerful immune molecule and increasing their immune cells’ ability to burn sugar, which is critical to attack the TB bacteria.
When infected with the drug-resistant strain, however, the mice’s immune cells did not burn more sugar, and they failed to produce much of the powerful immune molecule. They instead released a different immune molecule that is linked to a weak and potentially detrimental immune response to TB.
“People always thought that development of drug resistance just meant that there’s a change in how bacteria respond to antibiotics,” Dr. Khader said. “But this shows that the whole immune environment is changing in ways that we haven’t been fully aware of.”
More articles on clinical leadership and infection control:
Athenahealth data offers best predictions of flu season, study finds
Ebola containment efforts in Congo prove effective, health officials say
Scientists create cooling system for outbreak responders’ protective suits
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.